Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
cutting balloon
suture-based closure device
transcatheter aortic valve replacement
vascular closure
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
14
03
2023
received:
16
11
2022
accepted:
07
04
2023
medline:
12
6
2023
pubmed:
17
4
2023
entrez:
16
4
2023
Statut:
ppublish
Résumé
Suture-based vascular closure devices have been shown to be effective in hemostasis for procedures with vascular access. However, iatrogenic vascular occlusion may occur. The cutting balloon (CB) is a noncompliant balloon wrapped with 3-4 microsurgical blades that are intended to modify vascular lesions, but it may also be utilized to cut and release endovascular sutures. We report two cases in which the CB was employed as a bailout strategy to alleviate suture-related vascular occlusion after transcatheter aortic valve replacement. The CB can be effectively utilized to resolve suture-related vascular occlusion.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1235-1238Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Mohammadi S, Rodés-Cabau J, Kalavrouziotis D. TAVR access. J Am Coll Cardiol. 2019;74:2740-2742.
Danenberg HD. Pay attention on the road: TAVR and vascular complications. Cardiovasc Revasc Med. 2020;21:1074-1075.
Abdel-Wahab M, Hartung P, Dumpies O, et al. Comparison of a pure Plug-Based versus a primary suture-based vascular closure device strategy for transfemoral transcatheter aortic valve replacement: the CHOICE-CLOSURE randomized clinical trial. Circulation. 2022;145:170-183.
Kondo N, Oue K, Miyashita K, Tanaka S, Miyake Y. Iatrogenic common femoral artery occlusion caused by a Suture-Mediated Closure System: a case report. Ann Vasc Dis. 2021;14:368-371.
Lederman RJ, Babaliaros VC, Lisko JC, et al. Transcaval versus transaxillary TAVR in contemporary practice. JACC Cardiovasc Interv. 2022;15:965-975.
Yousef S, Arnaoutakis GJ, Gada H, Smith AJC, Sanon S, Sultan I. Transcatheter mitral valve therapies: state of the art. J Card Surg. 2022;37:225-233.
Albiero DR. Cutting balloon versus conventional balloon angioplasty for the treatment of coronary artery disease. Eur Cardiol Rev. 2005;1:48-52.
Boston Scientific. Peripheral Cutting Balloon. Accessed November 7, 2022. https://www.bostonscientific.com/en-US/products/catheters--balloon/peripheral-cutting-balloon.html
Boston Scientific. WOLVERINETM Cutting Balloon-surgical dilatation catheter. Accessed November 7, 2022. https://www.bostonscientific.com/en-US/products/balloons-cutting/wolverine-cutting-balloon.html
Miura Y, Koyama K, Kongoji K, Soejima K. Fenestration using a novel cutting balloon for acute vessel occlusion secondary to intramural hematoma following stent implantation. Cardiovasc Revasc Med. 2022;40s:239-242.
Case BC, Kumar S, Yerasi C, et al. Real-world experience of suture-based closure devices: insights from the FDA manufacturer and user facility device experience. Catheter Cardiovasc Interv. 2021;98:572-577.
Choi CH, Hall JK, Malaver D, Applegate RJ, Zhao DXM. A novel technique for postclosure of large-bore sheaths using two Perclose devices. Catheter Cardiovasc Interv. 2021;97:905-909.
Furlough CL, Desai SS, Azizzadeh A. Adjunctive technique for the use of ProGlide vascular closure device to improve hemostasis. J Vasc Surg. 2014;60:1693-1694.
Bangalore S, Arora N, Resnic FS. Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardiovasc Interv. 2009;2:549-556.
Noori VJ, Eldrup-Jørgensen J. A systematic review of vascular closure devices for femoral artery puncture sites. J Vasc Surg. 2018;68:887-899.
Hassan MF, Mixon T, Gray WT, Reddy R. Occlusion following the deployment of MANTA VCD after TAVR. J Card Surg. 2020;35:3148-3149.
Kmiec L, Zerdzitzki M, Schmid C, et al. Evaluation of the MANTA vascular closure device in transfemoral TAVI. Thorac Cardiovasc Surg. 2021.
Moccetti F, Wolfrum M, Bossard M, et al. Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms. Catheter Cardiovasc Interv. 2021;98:E462-E465.
Tarantini G. MANTA dedicated large-bore vessel closure device. Circ Cardiovasc Interv. 2019;12:e008203.
Dumpies O, Kitamura M, Majunke N, et al. Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: initial experience from a large European center. Cardiovasc Revasc Med. 2022;37:34-40.
van Wiechen MP, Kroon H, Hokken TW, et al. Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: predictors and bail-outs. Catheter Cardiovasc Interv. 2021;98:E737-E745.
van Wiechen MP, Tchétché D, Ooms JF, et al. Suture- or plug-based large-bore arteriotomy closure. JACC Cardiovasc Interv. 2021;14:149-157.